Trial · NCT03233724
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Activated partial thromboplastin time prolonged | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 0 | 2 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 0 | 2 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 1 | 4 | 1 |
| other | Activated partial thromboplastin time prolonged | Investigations | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 0 | 0 |
| other | Alkaline phosphatase increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 0 | 2 | 0 |
| other | Alkaline phosphatase increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 0 | 2 | 0 |
| other | Alkaline phosphatase increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 2 | 4 | 4 |
| other | Alkaline phosphatase increased | Investigations | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 0 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 1 | 2 | 7 |
| other | Anemia | Blood and lymphatic system disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 1 | 2 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 4 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 0 | 0 |
| other | Blood bilirubin increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 1 | 2 | 1 |
| other | Blood bilirubin increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 1 | 2 | 2 |
| other | Blood bilirubin increased | Investigations | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 4 | 0 |
| other | Blood bilirubin increased | Investigations | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 0 | 0 |
| other | Blurred vision | Eye disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Sunday, Monday, Tuesday (SuMT) | 1 | 2 | 1 |
| other | Blurred vision | Eye disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Monday-Tuesday (MT) | 0 | 2 | 0 |
| other | Blurred vision | Eye disorders | Decitabine 0.2mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 4 | 0 |
| other | Blurred vision | Eye disorders | Decitabine 0.17mg/kg + Tetrahydrouridine 10mg/kg Every (q) Tuesday,Wednesday (TW) x 2 Weeks q3Weeks | 0 | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03233724/events